Halaven is a halichondrin class microtubule dynamics inhibitor with a distinct binding profile.
Many diseases, such as cancer, diabetes, and schizophrenia, tend to be passed down through families.
The Bill & Melinda Gates Foundation has awarded Takeda Pharmaceuticals a $38 million grant to support development of a low-cost polio vaccine.
Allergan shares rose 2 percent in premarket trading.
These findings could have an impact on the future of nuclear medicine.
The economic studies were funded by the Illinois-based pharmaceutical company AbbVie.
Shares of Valeant Pharmaceuticals are sharply higher after the embattled drug company promised to do better with financial filing deadlines.
Epigenomics AG, the German-American cancer molecular diagnostics company, announced that Laboratory Corporation of America Holdings (LabCorp) is the first laboratory network in the U.S. to offer Epi proColon, a blood-based test for colorectal cancer screening.
Migraines are thought to cause pain because they cause a swelling of the blood vessels feeding the brain.
The safety of a controversial clot-busting drug has been investigated by researchers.
Researchers have discovered a new factor in the escalation of seizures.
Pembrolizumab produces positive responses that are long-lasting and with fewer side effects than traditional treatments in people with advanced melanoma.
Evidence suggests that bacteria living in the gut may remotely influence the activity of cells in the brain.
The discovery of a naturally occurring process known as RNAi (short for “RNA interference”) has enabled a new platform for drug development that can potentially serve as a basis for the creation of new types of therapeutics.
More than 10 percent of pregnant women develop serious complications during pregnancy. The underlying cause is often a poorly functioning placenta, the organ that nourishes and maintains the fetus.